Colloid solutions have been extensively used during resuscitation of shock patients. They were often selected over crystalloid solutions because of their expected ability to expand plasma volume faster than crystalloids and at a lower volume. Recent data from high quality trials have questioned the superior efficacy of colloids over crystalloids and shown clear side-effects of colloids in critically ill patients. Thus hydroxyethyl starch has been shown to increase the risk of kidney failure, bleeding and mortality in critically ill patients. Albumin has been associated with increased mortality in patients with traumatic brain injury. Therefore, current guidelines do not recommend choosing colloids over crystalloids. In spite of this, there appears to be a continued use of albumin solutions in intensive care patients. The reasons for this are unknown. It may be that clinicians still believe in the colloid theory, a belief that made be supported by observations of the albumin trials in intensive care patients, including small differences in potency and results of sub-group analyses. However, albumin is a limited and expensive resource and its use is not supported by high-quality data.